Global Cell Banking Market Trends, Opportunities, and Future
Global Cell Banking Market Trends, Opportunities, and Future
As Outsourcing of Cell Line Development Services Drives the Market, Contract Service Providers Focus on Providing End-to-end Services by Expanding the
11-Jan-2017
North America
Description
This research service on the global cell banking market addresses market sizing, emerging trends, and technologies and provides a snapshot of the key participants in the market. The base year considered is 2015 and forecasts are provided from 2016 to 2020.
The cell banking market is expected to grow at a CAGR of 16.7% till 2020, driven by specialized and technologically advanced services offered by CROs/CMOs, growing demand for gene and cell therapy, and increased partnerships with biopharmaceutical companies. Also, there are an increasing number of grants, incentives, and private investments in research on cell therapeutics and biopharmaceuticals. Master cell banking and storage accounted for the largest shares of cell banking revenue, among the different bank types, and the different phases of cell banking, respectively, in 2015.
The study also provides market forecasts for cell line development, a preliminary step to cell banking. Cell line development is driven by technological advancements and increasing demand for cancer therapeutics and monoclonal antibodies. Mammalian cell lines are the most used source for cell line development in all regions. The United States leads in cell line development and cell banking, closely followed by Europe and Asia-Pacific. The fastest growth rate was experienced in Asia-Pacific, with the hotbeds in India and China. Due to increasing demand for cell lines and cell banking, CMOs/CROs are focusing on providing end-to-end services by expanding their service portfolio and collaborating with biopharmaceutical companies.
Table of Contents
Key Findings
Scope and Segmentation
Market Overview
Market Revenue Forecasts Snapshot
Market Trends
Industry Value Chain
8 Big Market Themes for Cell Banking
Global Market Perspective
In-house and Outsourced Cell Banking—Large Pharma
In-house and Outsourced Cell Banking—Generic Pharma
In-house and Outsourced Cell Banking—Biotech
In-house and Outsourced Cell Banking
Out-sourced Cell Banking Trends
Regional Trends in the Cell Banking Market
Market Drivers
Drivers Explained
Drivers Explained (continued)
Market Restraints
Restraints Explained
Restraints Explained (continued)
Market Revenue Forecasts Approach
Cell Line Development Market—Revenue Forecast
Revenue Forecast Discussion
Cell Banking Market—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
Biologics Safety Testing Market—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Transformation in Pharmaceutical Industry Eco-system
4 Major Growth Opportunities
Strategic Imperatives for CMOs and CROs
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Related Research
Popular Topics
No Index | No |
---|---|
Podcast | No |
Author | Shweta Pankaj |
Industries | Healthcare |
WIP Number | 9AB9-00-63-00-00 |
Is Prebook | No |